Bioethics
Systematic review: Financial payments from the pharmaceutical industry is associated with more physician prescribing of the drug made by the company that they got the payments from
25 Nov, 2020 | 09:07h | UTCAre Financial Payments From the Pharmaceutical Industry Associated With Physician Prescribing? A Systematic Review – Annals of Internal Medicine (link to abstract – $ for full-text)
Commentary: Financial payments from drug industry associated with physician prescribing – American College of Physicians
Commentary from the author on Twitter (thread – click for more)
"Are Financial Payments From the Pharmaceutical Industry Associated With Physician Prescribing?"
Our latest on physician-industry COI is out today in @AnnalsofIM!Not to bury the lede, the answer is "yes."
Thread to follow.https://t.co/2lfAjWSQuq
1/— Aaron Mitchell (@TheWonkologist) November 24, 2020
Opinion: For billion-dollar COVID vaccines, basic government-funded science laid the groundwork
19 Nov, 2020 | 09:33h | UTC
Why scientists fear the “toxic” Covid-19 debate
6 Nov, 2020 | 09:57h | UTCWhy scientists fear the “toxic” Covid-19 debate – NewStatesman
Related: Disagree on Covid-19, but don’t demonise other views – Research Professional News
Perspective: Rich countries reserve billions of Covid-19 vaccine doses even before there is one
6 Nov, 2020 | 09:52h | UTCRich Countries Reserve Billions Of Covid-19 Vaccine Doses Even Before There Is One – Forbes
Opinion: Disagree on Covid-19, but don’t demonize other views
5 Nov, 2020 | 09:04h | UTCDisagree on Covid-19, but don’t demonise other views – Research Professional News
Key populations for early COVID-19 immunization: Preliminary guidance for policy
4 Nov, 2020 | 09:46h | UTC
Commentary on Twitter
Preliminary guidance on key populations for early #COVID19 immunization: groups include those at high risk for severe illness and death, essential workers, #Indigenous communities. Read the evidence-based guideline https://t.co/Tc3vBdJxSV @CPHO_Canada @GovCanHealth @CaroQuach pic.twitter.com/3vyGkL87AD
— CMAJ (@CMAJ) November 3, 2020
Association between industry payments to physicians and device selection in ICD implantation
4 Nov, 2020 | 09:40h | UTCAssociation Between Industry Payments to Physicians and Device Selection in ICD Implantation – JAMA (free for a limited period)
Editorial: Reconsidering Health Care Fraud and Abuse Laws (free for a limited period)
Commentary on Twitter
More evidence that payments from industry to physicians influence clinical decisions. Great paper led by @AmarMD99 in @YaleCardiology shows that patients most likely to receive ICD/CRD made by manufacturer that provided largest payments to their physician https://t.co/P1Hh2VAxur
— Joseph Ross (@jsross119) November 3, 2020
Influence and management of conflicts of interest in randomized clinical trials: qualitative interview study
2 Nov, 2020 | 02:22h | UTC
Commentary on Twitter
In a great qualitative interview study @bmj_latest @LasseOstengaard, @AndreasLundh2 & colleagues show some staggering trialist comments on how trial sponsors tried to influence the clinical trials with manipulation, spin and selective reporting https://t.co/KN25JeYErU pic.twitter.com/2leb0OQmCG
— Lars Jørgensen MD PhD (@LarsJorgensenMD) October 30, 2020
The ‘very, very bad look’ of remdesivir, the first FDA-approved COVID-19 drug
30 Oct, 2020 | 01:14h | UTCThe ‘very, very bad look’ of remdesivir, the first FDA-approved COVID-19 drug – Science
Commentaries on Twitter
Remdesivir, despite failing in Solidarity trial, received FDA approval without input from outside advisory group. EU cut pricing deal with Gilead without knowing Solidarity data. @kakape and I explain in "The ‘very, very bad look’ of remdesivir" https://t.co/yTKq2A1WQT pic.twitter.com/NhBLum09VG
— Jon Cohen (@sciencecohen) October 28, 2020
Uncovering a scandal about Gilead and Remdesivir
Deep reporting by @sciencecohen and @kakape @ScienceMagazine
The company knew the #SOLIDARITY trial data well before it its preprint. And so did the FDA before giving a full approval, w/o external review https://t.co/4REMEwTvc5— Eric Topol (@EricTopol) October 28, 2020
Opinion: For now, it’s unethical to use human challenge studies for SARS-CoV-2 vaccine development
30 Oct, 2020 | 01:09h | UTC
Dozens to be deliberately infected with coronavirus in UK ‘human challenge’ trials
21 Oct, 2020 | 09:25h | UTCDozens to be deliberately infected with coronavirus in UK ‘human challenge’ trials – Nature
Commentaries: U.K. Preparing COVID-19 Vaccine Trials That Deliberately Expose Study Subjects – NPR AND UK plan to be first to run human challenge Covid trials – BBC
Richard Smith: Are all lives and deaths equal?
15 Oct, 2020 | 08:58h | UTCRichard Smith: Are all lives and deaths equal? – The BMJ Opinion
Infecting volunteers with coronavirus may be one way to test potential vaccines. But there are risks.
13 Oct, 2020 | 01:02h | UTC
Research integrity: Nine ways to move from talk to walk
13 Oct, 2020 | 01:01h | UTCResearch integrity: nine ways to move from talk to walk – Nature
Framework for equitable allocation of COVID-19 vaccine
4 Oct, 2020 | 23:34h | UTCRelated: WHO SAGE values framework for the allocation and prioritization of COVID-19 vaccination – World Health Organization AND An ethical framework for global vaccine allocation – Science AND US Adults’ Preferences for Public Allocation of a Vaccine for Coronavirus Disease 2019 – JAMA Network Open
Video: Who gets coronavirus vaccine first?
4 Oct, 2020 | 23:33h | UTCWho Gets Coronavirus Vaccine First? – JAMA
John P.A. Ioannidis: Scientific petitions and open letters in the Covid-19 era
4 Oct, 2020 | 23:27h | UTCJohn P.A. Ioannidis: Scientific petitions and open letters in the covid-19 era – The BMJ Opinion
Perspective: The incompatibility of patient-centered care with fee-for-service payment
29 Sep, 2020 | 09:57h | UTCThe Incompatibility of Patient-Centered Care With Fee-for-Service Payment – JAMA Internal Medicine
Commentary on Twitter
Deeply moving, beautiful, insightful article. The US health care system MUST change the way we pay. That's the only way we will improve health, give the right care, and restore the centrality of care-giving.https://t.co/5cc59glIMm
— Dr. Tom Frieden (@DrTomFrieden) September 28, 2020
COVID-vaccine results are on the way — and scientists’ concerns are growing
28 Sep, 2020 | 01:33h | UTCCOVID-vaccine results are on the way — and scientists’ concerns are growing – Nature
Commentary on Twitter
Several ongoing coronavirus-vaccine trials could announce game-changing results next month. Scientists, though, have growing concerns. Here are the three areas they are watching closely. https://t.co/QxyA1zM0rY
— Nature (@nature) September 26, 2020
Evaluating and deploying Covid-19 vaccines — The importance of transparency, scientific integrity, and public trust
24 Sep, 2020 | 09:27h | UTC
Britain will ‘host world’s first Covid-19 vaccine challenge trial’
24 Sep, 2020 | 09:22h | UTC
Interesting conversation: Lockdowns, COVID mortality, & when science & politics collide (w/Dr. Eran Bendavid)
22 Sep, 2020 | 09:49h | UTCLockdowns, COVID Mortality, & When Science & Politics Collide (w/Dr. Eran Bendavid) (via @ZDoggMD)
To find a vaccine for COVID-19, will we have to deliberately infect people?
22 Sep, 2020 | 09:40h | UTCTo find a vaccine for COVID-19, will we have to deliberately infect people? – National Geographic
Who gets a COVID vaccine first? Access plans are taking shape
20 Sep, 2020 | 21:24h | UTCWho gets a COVID vaccine first? Access plans are taking shape – Nature
Related: WHO Guidance: Allocation and prioritization of COVID-19 vaccination
Commentary on Twitter
Advisory groups around the world are working out plans for who should get priority access to a #covid19 vaccine: https://t.co/9g67rFJUrT pic.twitter.com/BLhAcKiVCK
— Nature News & Comment (@NatureNews) September 18, 2020
WHO Guidance: Allocation and prioritization of COVID-19 vaccination
17 Sep, 2020 | 09:42h | UTCCommentary: World Health Organization announces distribution plan for COVID-19 vaccine – ABD News
Related: An ethical framework for global vaccine allocation – Science